help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogirala, R. G.
Right arrow Articles by Finkel, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogirala, R. G.
Right arrow Articles by Finkel, R. I.

Am. J. Respir. Crit. Care Med., Vol 152, No. 5, 11 1995, 1461-1466.

Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study

RG Ogirala, TM Sturm, TK Aldrich, FF Meller, EB Pacia, AM Keane and RI Finkel
Department of Medicine, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York 10467-2490, USA.

Effective and less toxic treatments are needed for patients with severe, steroid-dependent asthma. Both low-dose oral methotrexate and high-dose intramuscular triamcinolone have been recommended for these patients. We compared the effects of these two medications on pulmonary function, peak flow rates, airway reactivity, oral steroid use, emergency room (ER) visits, and hospitalizations in patients with steroid-dependent, life-threatening asthma. In a randomized, placebo- controlled, double-blind study, we investigated 19 such patients. Six of the patients (Group I) received a single dose of 360 mg triamcinolone intramuscularly with placebo methotrexate; seven patients (Group II) received placebo triamcinolone followed by low-dose oral methotrexate (a first dose of 7.5 mg followed by 15 mg weekly); and six patients (Group III) received placebo triamcinolone with placebo methotrexate. All patients used the same high-dose inhaled steroids. The patients took tapering courses of oral steroids when needed, but attempted to reduce their oral steroid use whenever possible. Methacholine challenge testing was performed every 6 wk, pulmonary function tests every 4 wk, and home peak-flow measurements twice daily. Oral steroid use, ER visits, and hospitalizations were also monitored. The patients in the triamcinolone treatment group showed a significant and sustained increase in home peak-flow rates, and their FEV1 persistently improved by a mean of 40% (p < 0.05), whereas the FEV1 of the patients in the methotrexate treatment and placebo groups remained near baseline. The PC20 in the triamcinolone group increased progressively (p > 0.05), and the improvements in total mean reactivity were greater in this group than in either of the other two groups (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
PediatricsHome page
A. L. Fuhlbrigge, S. T. Weiss, K. M. Kuntz, A. D. Paltiel, and for the CAMP Research Group
Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With Asthma
Pediatrics, August 1, 2006; 118(2): e347 - e355.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. E. Strek
Difficult asthma.
Proceedings of the ATS, January 1, 2006; 3(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Wenzel
Severe Asthma in Adults
Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 149 - 160.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. T. Kitch, A. D. Paltiel, K. M. Kuntz, D. W. Dockery, J. P. Schouten, S. T. Weiss, and A. L. Fuhlbrigge
A Single Measure of FEV1 Is Associated With Risk of Asthma Attacks in Long-term Follow-up
Chest, December 1, 2004; 126(6): 1875 - 1882.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. S. Niven and G. Argyros
Alternate Treatments in Asthma
Chest, April 1, 2003; 123(4): 1254 - 1265.
[Full Text] [PDF]


Home page
ChestHome page
S. Wenzel
Severe/Fatal Asthma
Chest, March 1, 2003; 123(2007): 405S - 410S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008